arrow
K

Katharina Holstein

university of kiel
H指数:20
被引数:1,642

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia A

艾美珠单抗的持续生存获益及获得性血友病A中免疫抑制治疗的推迟

2025-08-140
OAAI
Design of an international, phase IV, open-label study of simoctocog alfa in women/girls with hemophilia A undergoing surgery (NuDIMENSION)
2024-12-010
OAAI
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary

在德国,emicizumab对无因子VIII抑制剂的严重a型血友病患者的疗效: smart mediceary记录的现实数据评估

2024-11-290
OAAI
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions
2024-09-301
OAAI
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study
2023-11-0118
PRE
Sixth Åland Island Conference on von Willebrand disease
2022-07-211
OA
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain
2022-03-085
OA
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)

血友病基因治疗管理中的电子日记: 德国,奥地利和瑞士血栓形成和止血学会 (GTH) 专家组的观点

2022-02-193
OA